ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Biotherapy

Neuroendocrinology

Volumn 90, Issue 2, 2009, Pages 209-213

  Öberg, Kjell ^a   Ferone, Diego ^b   Kaltsas, Gregory ^c   Knigge, Ulrich Peter ^d   Taal, Babs ^e   Plöckinger, Ursula ^f   Åkerström, Göran ^a   Annibale, Bruno ^g   Arnold, Rudolf ^h   Bajetta, Emilio ⁱ   Barkmanova, Jaroslava ^j   Chen, Yuan Jia ^k   Costa, Frederico ^l   Couvelard, Anne ^m   Davar, Joseph ⁿ   De Herder, Wouter ^o   Delle Fave, Gianfranco ^p   Eriksson, Barbro ^a   Falconi, Massimo ^q   Gross, David ^r   Grossman, Ashley ^s   Gustafsson, Björn ^t   Hyrdel, Rudolf ^u   Ivan, Diana ^h   Kianmanesh, Reza ^v   Kloppel, Günter ^w   Komminoth, Paul ^x   Kos Kudła, Beata ^y   Kwekkeboom, Dik ^o   Lebtahi, Rachida ^z   Lewington, Val ^aa   McNicol, Anne Marie ^ab   Mitry, Emmanuel ^ac   Nilsson, Ola ^ad   O'Connor, Juan ^ae   O'Toole, Dermot ^af   Pape, Ulrich Frank ^f   Papotti, Mauro ^ag   Pavel, Marianne ^f   Perren, Aurel ^ah   Platania, Marco ⁱ   Rindi, Guido ^ai   Ruszniewski, Philippe ^m   Salazar, Ramon ^aj   Scarpa, Aldo ^ak   Scheidhauer, Klemens ^ah   Scoazec, Jean Yves ^al   Sundin, Anders ^a   Szpak, Waldemar ^am   Vitek, Pavel ^j   Vullierme, Marie Pierre ^m   Wiedenmann, Bertram ^f   more..

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GENOA   (Italy)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

^d Rigshospitalet   (Denmark)

^e Netherlands Cancer Centre   (Netherlands)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j CHARLES UNIVERSITY   (Czech Republic)

^k PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^l HOSPITAL SÍRIO LIBANÊS   (Brazil)

^m BEAUJON HOSPITAL   (France)

ⁿ ROYAL FREE HOSPITAL   (United Kingdom)

^o ERASMUS MEDICAL CENTER   (Netherlands)

^p SAPIENZA UNIVERSITY OF ROME   (Italy)

^q UNIVERSITY OF VERONA   (Italy)

^r HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^s ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^t TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^u Martinska Fakultna Nemocnica   (Slovakia)

^v HÔPITAL LOUIS MOURIER   (France)

^w TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^x Institute for Pathology   (Switzerland)

^y MEDICAL UNIVERSITY OF SILESIA   (Poland)

^z BICHAT HOSPITAL   (France)

^aa INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ab GLASGOW ROYAL INFIRMARY   (United Kingdom)

^ac HÔPITAL AMBROISE PARÉ   (France)

^ad SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ae INSTITUTO ALEXANDER FLEMING   (Argentina)

^af ST JAMES S HOSPITAL   (Ireland)

^ag UNIVERSITY OF TURIN   (Italy)

^ah TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ai UNIVERSITY OF PARMA   (Italy)

^aj CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ak UNIVERSITY OF VERONA   (Italy)

^al EDOUARD HERRIOT HOSPITAL   (France)

^am Westville Hospital   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CYCLOSPORIN A; OCTREOTIDE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; SOMATOSTATIN DERIVATIVE;

BIOTHERAPY; CANCER CHEMOTHERAPY; CANCER THERAPY; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DIET; DRUG DOSE TITRATION; ELECTROCARDIOGRAM; EVENING DOSAGE; FEVER; FLU LIKE SYNDROME; HUMAN; HYPOTHYROIDISM; INJECTION SITE PAIN; LACTATION; NEUROENDOCRINE TUMOR; PATIENT INFORMATION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SLUDGE;

ANTINEOPLASTIC AGENTS; HUMANS; INTERFERON-ALPHA; NEUROENDOCRINE TUMORS; SOMATOSTATIN;

EID: 69749110763     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183751     Document Type: Conference Paper

References (9)

1. Oberg K, Kvols L, Caplin M, Delle Fave G, De Herder W, Rindi G, et al: Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004;15:966-973. (Pubitemid 39004355)
2. Plöckinger U, Wiedenmann B: Neuroendocrine tumors. Biotherapy. Best Pract Res Clin Endocrinol Metab 2007;21:145-162.
3. Rindi G, de Herder WW, O'Toole D, Wiedenmann B: onsensus guidelines for the management of patients with digestive neuroendocrine tumors: he second event and some final considerations. Neuroendocrinology 2008;87:5-7. (Pubitemid 350308289)
4. Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, et al: Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 2006;84:158-164.
5. Jensen RT, Rindi G, Arnold R, Lopes JM, Brandi ML, Bechstein WO, et al: ell-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 2006;84:165-172.
6. Jensen RT, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V, et al: astrinoma (duodenal and pancreatic). Neuroendocrinology 2006;84:173-182.
7. De Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, et al: Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006;84:183-188.
8. O'Toole D, Salazar R, Falconi M, Kaltsas G, Couvelard A, de Herder WW, et al: Rare functioning pancreatic endocrine tumors. Neuroendocrinology 2006;84:189-195. (Pubitemid 46361053)
9. Nilsson O, Van Cutsem E, Delle Fave G, Yao JC, Pavel ME, McNicol AM, et al: Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 2006;84:212-215. (Pubitemid 46361055)